Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series

medRxiv(2020)10.1101/2020.05.13.20087734Source: DataRank Database

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (49)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Alice S. Chau ORCID,Mikala Egeblad ORCID,Betsy Barnes ORCID,Tobias Janowitz ORCID,Andrew Weber ORCID

Live enrichment

PubMed:32511514 OpenAlex:https://openalex.org/W3025664390

National Institutes of Health

Grant: 1R01AR076242-01

IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis

National Institutes of Health

Grant: 5U54AI082973-02

Primary Immune Deficiency Treatment Consortium

National Institutes of Health

Grant: 5P30CA045508-30

CSHL Cancer Center Support Grant

National Institutes of Health

Grant: 5U54AI082973-12

Primary Immune Deficiency Treatment Consortium

National Institutes of Health

Grant: 3P30CA045508-08S1

CSHL CANCER CENTER SUPPORT GRANT

NCI NIH HHS

Grant: P30 CA045508

NIAMS NIH HHS

Grant: R01 AR076242

NIAID NIH HHS

Grant: U54 AI082973

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/05/15/2020.05.13.20087734.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.05.13.20087734

repositoryhttps://doi.org/10.1101/2020.05.13.20087734

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32511514

Fields of Study

Respiratory Support and MechanismsCystic Fibrosis Research AdvancesLong-Term Effects of COVID-190301 basic medicine03 medical and health sciences0303 health sciences

Keywords

MedicineARDSNebulizerExtracorporeal membrane oxygenationTolerabilityMechanical ventilationBronchodilatorCystic fibrosisAnesthesiaSputumIntensive care medicineLungInternal medicineAdverse effectAsthmaPathologyAdultMalePneumonia, ViralShort ReportRM1-950QD415-436Neutrophil extracellular trapsBiochemistryArticleIntubation, IntratrachealDeoxyribonuclease IHumansAlbuterolPandemicsAgedSARS-CoV-2Nebulizers and VaporizersCOVID-19Respiration, ArtificialRecombinant ProteinsBronchodilator AgentsCoronavirusDornase alfaMucopurulent secretionsFemaleTherapeutics. PharmacologyCoronavirus Infections

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being